Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Rule 8.3- Consort Medical Plc

3 Mar 2010 10:54

RNS Number : 0089I
State Street Global Advisors
03 March 2010
 



 

FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE 

(Rule 8.3 of the City Code on Takeovers & Mergers)

 

1. KEY INFORMATION

 

Name of Person State Street

Dealing (Note 1) Global Advisors & Affiliates

Company Dealt In Consort Medical Plc

Class of Relevant Security Ord

to Which the Dealings

Being Disclosed

Relate (Note 2)

Date of Dealing 2/3/2010

 

2. INTERESTS, SHORT POSITIONS & RIGHTS TO SUBSCRIBE

 

 

 

(a) Interests & Short Positions (following dealing) in 

the Class of Relevant Security Dealt In (Note 3)

 

Class of Relevant Security: Long Short

Number % Number %

(1) Relevant Securities 292499 1.01057

(2) Derivatives 0 0.00000 0 0.00000

other than options

(3) Options &

Agreements to

Purchase/Sell

Total 292499 1.01057 0 0.00000

 

(b) Interests & Short Positions in Relevant Securities of the Company 

(ex.Class Dealt In) (Note 3)

 

 

Class of Relevant Security: Long Short

Number % Number %

(1) Relevant Securities

(2) Derivatives

other than options

(3) Options &

Agreements to

Purchase/Sell

Total

 

(c) Rights to Subscribe (Note 3)

 

Class of Relevant Security: Details

 

3. DEALINGS (Note 4)

 

(a) Purchases & Sales

 

Purchase / Number of Price

Sale Securities per Unit

SELL 771 3.57

 

(b) Derivatives Transactions (other than options)

 

Product Name (e.g. CFD) Long/Short No./Securites Price/Unit

(Note 6) (Note 7) (Note 5)

 

(c) Options Transactions in Respect of Existing Securities

(i) Writing, Selling, Purchasing or Varying

 

Product Name Write,Sell No/Securities Exercise Type

(eg call option) Purchasing, Which the Price (e.g. USA,

Varying etc. Optn Relates European etc)

Relates-Note7

 

Expiry Date Option Money

Paid/Received

per Unit

(Note 5)

 

(ii) Exercising

 

Product Name Number of Exercise

(eg call option) Securities Price per

Unit (Note 5)

 

(d) Other Dealings (including new securities) (Note 4)

 

Nature of Transaction Details Price / Unit

(Note 8) if applicable

(Note 5)

 

4. OTHER INFORMATION

 

(a)Agreements, Arrangements or Understandings Relating to Options or Derivatives

Full details of any agreement, arrangement or understanding between the person

disclosing & any other person relating to the voting rights of any relevant

securities under any option referred to on this form or relating to the voting

rights or future acquisition or disposal of any relevant securities to which

any derivative referred to on this form is referenced.

If none, this should be stated.

 

 

 

Is a Supplemental Form 8 Attached? (Note 9) NO

 

Disclosure Date 03/03/2010

Contact Name Chetan Shah

Telephone Number 020 3395 6564

If Connected EFM N/A

Name of Offeree/Offeror

With Which Connected

If Connected EFM N/A

State Nature of

Connection (Note 10)

 

Notes:

The Notes on Form 8.3 can be viewed on the

Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETUGUWAWUPUGUW
Date   Source Headline
15th Jun 20123:12 pmRNSDirector/PDMR Shareholding
14th Jun 20127:00 amRNSDirectorate
14th Jun 20127:00 amRNSPreliminary Results
6th Jun 20121:57 pmRNSBlocklisting Interim Review
1st May 201210:21 amRNSTotal Voting Rights
30th Apr 20127:00 amRNSFDA Approval Proprietary Integrated Dose Counter
20th Apr 201210:54 amRNSHolding(s) in Company
16th Apr 201211:37 amRNSBlocklisting Interim Review
28th Mar 20124:36 pmRNSHolding(s) in Company
22nd Mar 20129:58 amRNSAnnual Information Update
20th Mar 20124:25 pmRNSReplacement Interim Management Statement
20th Mar 20121:07 pmRNSInterim Management Statement
1st Mar 20129:00 amRNSTotal Voting Rights
17th Feb 201210:09 amRNSHolding(s) in Company
23rd Jan 20129:45 amRNSBlocklisting Interim Review
13th Dec 20112:25 pmRNSDirector/PDMR Shareholding
2nd Dec 20111:34 pmRNSBlocklisting Interim Review
1st Dec 20117:00 amRNSInterim results for the six months ended 31/10/11
19th Oct 20114:03 pmRNSHolding(s) in Company
17th Oct 20113:13 pmRNSHolding(s) in Company
14th Oct 20119:39 amRNSBlocklisting Interim Review
7th Oct 201112:13 pmRNSHolding(s) in Company
5th Oct 20114:47 pmRNSHolding(s) in Company
4th Oct 20117:00 amRNSSecond Nasal Drug Delivery Contract
27th Sep 20114:33 pmRNSHolding(s) in Company
26th Sep 20113:01 pmRNSHolding(s) in Company
2nd Sep 201110:21 amRNSTotal Voting Rights
1st Sep 20112:50 pmRNSResult of AGM
1st Sep 20112:47 pmRNSDirectorate Change
1st Sep 201112:40 pmRNSInterim Management Statement
1st Sep 20117:00 amRNSNasal Drug Delivery Contract
24th Aug 20114:35 pmRNSHolding(s) in Company
2nd Aug 20111:51 pmRNSDirector/PDMR Shareholding
2nd Aug 20111:47 pmRNSDirector/PDMR Shareholding
28th Jul 20119:14 amRNSAnnual Financial Report
20th Jul 20117:00 amRNSFurther re Investment in Atlas Genetics
30th Jun 20111:58 pmRNSTotal Voting Rights
24th Jun 20119:06 amRNSHolding(s) in Company
21st Jun 201112:33 pmRNSBlocklisting Interim Review
16th Jun 20117:00 amRNSPreliminary results for the year ended 30/04/11
2nd Jun 20117:00 amRNSBlocklisting Interim Review
10th May 20119:27 amRNSHolding(s) in Company
14th Apr 201110:20 amRNSBlocklisting Interim Review
4th Apr 201110:29 amRNSHolding(s) in Company
1st Apr 20111:51 pmRNSHolding(s) in Company
23rd Mar 20112:04 pmRNSAnnual Information Update
14th Mar 20117:00 amRNSInterim Management Statement
15th Feb 20114:14 pmRNSHolding(s) in Company
9th Feb 201111:15 amRNSDirectorate Change
7th Feb 20117:00 amRNSPartners with Atlas Genetics

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.